Financhill
Buy
54

IBIO Quote, Financials, Valuation and Earnings

Last price:
$3.65
Seasonality move :
29.56%
Day range:
$3.10 - $3.40
52-week range:
$1.05 - $4.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.25x
Volume:
282K
Avg. volume:
262.5K
1-year change:
168.64%
Market cap:
$31.3M
Revenue:
$225K
EPS (TTM):
-$2.69

Analysts' Opinion

  • Consensus Rating
    iBio has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $4.78, iBio has an estimated upside of 50.79% from its current price of $3.17.
  • Price Target Downside
    According to analysts, the lowest downside price target is $3.60 representing -13.57% downside risk from its current price of $3.17.

Fair Value

  • According to the consensus of 2 analysts, iBio has 50.79% upside to fair value with a price target of $4.78 per share.

IBIO vs. S&P 500

  • Over the past 5 trading days, iBio has underperformed the S&P 500 by -0.07% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • iBio does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • iBio has grown year-over-year revenues for 1 quarter straight. In the most recent quarter iBio reported revenues of $200K.

Earnings Growth

  • iBio has grown year-over-year earnings for 0 quarters straight. In the most recent quarter iBio reported earnings per share of -$0.48.
Enterprise value:
25.2M
EV / Invested capital:
1.70x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.56x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-60.65%
Net Income Margin (TTM):
--
Return On Equity:
-110.9%
Return On Invested Capital:
-83.08%
Operating Margin:
-2209.5%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $72.7M -- -- -- $200K
Gross Profit -- -- -- -- --
Operating Income -$35.5M -$20.7M -$15.6M -$4.5M -$4.4M
EBITDA -$32.5M -$19.4M -$12.8M -$4.1M -$4M
Diluted EPS -$177.03 -$15.20 -$2.69 -$4.42 -$0.48
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $110.9M $67.5M $38.2M $19.7M $8.3M
Total Assets $145.4M $126.4M $51.8M $34M $21.7M
Current Liabilities $6.1M $8.3M $27.8M $21.6M $4.7M
Total Liabilities $38.1M $35.9M $33M $24.8M $7.8M
Total Equity $107.3M $90.6M $18.8M $9.2M $13.9M
Total Debt $600K $22.1M $16M $12.7M $880K
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations -$39M -$18.9M -$16.1M -$4.7M -$3.9M
Cash From Investing -$232K $8.3M $1.6M -- -$2K
Cash From Financing -$1.9M $10.7M $17.7M $4M -$152K
Free Cash Flow -$50M -$19.2M -$16.1M -$4.7M -$3.9M
IBIO
Sector
Market Cap
$31.3M
$43.5M
Price % of 52-Week High
63.66%
47.5%
Dividend Yield
0%
0%
Shareholder Yield
-72.35%
-0.74%
1-Year Price Total Return
168.64%
-35.82%
Beta (5-Year)
-3.256
0.753
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $3.33
200-day SMA
Buy
Level $2.33
Bollinger Bands (100)
Buy
Level 2.23 - 2.97
Chaikin Money Flow
Sell
Level -949.2M
20-day SMA
Buy
Level $3.09
Relative Strength Index (RSI14)
Buy
Level 54.72
ADX Line
Buy
Level 34.6
Williams %R
Neutral
Level -57.007
50-day SMA
Buy
Level $2.76
MACD (12, 26)
Buy
Level 0.20
25-day Aroon Oscillator
Buy
Level 76
On Balance Volume
Neutral
Level 1.9B

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-15.07)
Sell
CA Score (Annual)
Level (-2.3181)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (6.114)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Stock Forecast FAQ

In the current month, IBIO has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IBIO average analyst price target in the past 3 months is $4.78.

  • Where Will iBio Stock Be In 1 Year?

    According to analysts, the consensus estimate is that iBio share price will rise to $4.78 per share over the next 12 months.

  • What Do Analysts Say About iBio?

    Analysts are divided on their view about iBio share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that iBio is a Sell and believe this share price will drop from its current level to $3.60.

  • What Is iBio's Price Target?

    The price target for iBio over the next 1-year time period is forecast to be $4.78 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is IBIO A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for iBio is a Buy. 2 of 2 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of IBIO?

    You can purchase shares of iBio via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase iBio shares.

  • What Is The iBio Share Price Today?

    iBio was last trading at $3.65 per share. This represents the most recent stock quote for iBio. Yesterday, iBio closed at $3.17 per share.

  • How To Buy iBio Stock Online?

    In order to purchase iBio stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Will Palantir Stock Be Worth in 2030?
What Will Palantir Stock Be Worth in 2030?

Palantir Technologies (NYSE: PLTR) has emerged from a growth slowdown…

Is Rollins Stock a Buy, Sell or Hold?
Is Rollins Stock a Buy, Sell or Hold?

Pest control giant Rollins (NYSE:ROL) is the parent company of…

Why Did Bill Ackman Buy Uber?
Why Did Bill Ackman Buy Uber?

In early 2025, billionaire investor Bill Ackman, CEO of Pershing…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 111x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
65
ATEX alert for Feb 12

Anterix [ATEX] is down 0.72% over the past day.

Buy
87
GDS alert for Feb 12

GDS Holdings [GDS] is up 0.32% over the past day.

Sell
30
SPSC alert for Feb 12

SPS Commerce [SPSC] is up 0.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock